The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of sirolimus in combination with metronomic chemotherapy (CHOAnome) in children with recurrent and/or refractory solid and CNS tumors.
 
Kathryn Sutton
No Relationships to Disclose
 
Kevin Ginn
No Relationships to Disclose
 
Zhulin He
Stock and Other Ownership Interests - Lilly; Lilly (I)
 
Lindsey Hoffman
Employment - Johnson & Johnson
Honoraria - AstraZeneca
 
William Petersen
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Emi Caywood
No Relationships to Disclose
 
Muna Qayed
Honoraria - Medexus Pharmaceuticals
 
Stacy Senn
No Relationships to Disclose
 
Cynthia Wetmore
Employment - Zentalis
 
Howard Katzenstein
Employment - EMD Serono; Merck
 
Thomas Cash
Consulting or Advisory Role - US WorldMeds; Y-mAbs Therapeutics
Research Funding - Celgene (Inst); Lilly (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - United Therapeutics; Y-mAbs Therapeutics